Favorites Sign in
  1. Home
  2. Companies
  3. Stock argenx SE
argenx SE logo

argenx SE ARGX

$ 894.61 -3.96%
report update icon

Quarterly report 2025-Q4
added 05-06-2026

Country

 niderlandNiderland

IPO year

 2017

Industry

 Biotechnology

Stock Exchange

 NASDAQ GLOBAL

Shares

 61.3 M

Market Cap[1]

 $ 54.8 B

EBITDA (LTM)

 $ 1.05 B

P/E (LTM)

 49.010911

P/S (LTM)

 -

EPS (LTM)

 21.08

Other stocks of industry "Biotechnology"

Issuer Price % 24h Market Cap Exchange Country
Aileron Therapeutics Aileron Therapeutics
ALRN
 		- 10.36 % $ 9.8 M Nasdaq Global Select Market usaUSA
AlloVir AlloVir
ALVR
 		- 4.14 % $ 49.1 M Nasdaq Global Select Market usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
 		- - $ 5.18 B Nasdaq Global Select Market,SPB usaUSA
Athira Pharma Athira Pharma
ATHA
 		- - $ 269 M Nasdaq Global Select Market usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
 		- -52.27 % $ 4.45 M Nasdaq Global Select Market usaUSA
AVROBIO AVROBIO
AVRO
 		- 1083.1 % $ 745 M Nasdaq Global Select Market usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
 		- - $ 96.9 B Nasdaq Global Select Market britainBritain
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
 		- -2.5 % $ 5.88 M Nasdaq Capital Market usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
 		- 0.49 % $ 251 B Nasdaq Global Select Market cayman-islandsCayman-islands
EyePoint Pharmaceuticals EyePoint Pharmaceuticals
EYPT
 		$ 0.36 -8.84 % $ 26.4 K Nasdaq Global Market usaUSA
Bio-Path Holdings Bio-Path Holdings
BPTH
 		- - $ 100 K Nasdaq Capital Market usaUSA
Cara Therapeutics Cara Therapeutics
CARA
 		- -3.03 % $ 260 M Nasdaq Global Market,SPB usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
 		- -0.88 % $ 598 M Nasdaq Capital Market usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
 		- -16.75 % $ 25.8 M Nasdaq Capital Market usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
 		- -5.98 % $ 34.1 M Nasdaq Capital Market usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
 		- -4.36 % $ 27 M Nasdaq Capital Market usaUSA
Diffusion Pharmaceuticals Diffusion Pharmaceuticals
DFFN
 		- 11.68 % $ 8.97 M Nasdaq Capital Market usaUSA
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
 		- -5.68 % $ 8.28 M Nasdaq Global Market usaUSA
Enochian Biosciences Enochian Biosciences
ENOB
 		- - $ 40.5 M Nasdaq Capital Market usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
 		- - $ 661 M Nasdaq Global Market,SPB usaUSA
Evofem Biosciences Evofem Biosciences
EVFM
 		- 7.55 % $ 38.1 M Nasdaq Capital Market usaUSA
Eyenovia Eyenovia
EYEN
 		- 49.81 % $ 13.2 M Nasdaq Capital Market usaUSA
FibroGen FibroGen
FGEN
 		- - $ 889 M Nasdaq Global Select Market,SPB usaUSA
Homology Medicines Homology Medicines
FIXX
 		- 0.77 % $ 53.4 M Nasdaq Global Select Market usaUSA
Amicus Therapeutics Amicus Therapeutics
FOLD
 		- - $ 4.47 B Nasdaq Global Market,SPB usaUSA
Frequency Therapeutics Frequency Therapeutics
FREQ
 		- - $ 528 M Nasdaq Global Select Market usaUSA
Galecto Galecto
GLTO
 		- - $ 762 M Nasdaq Global Select Market danmarkDanmark
GlycoMimetics GlycoMimetics
GLYC
 		- 9357.83 % $ 1.01 B Nasdaq Global Market usaUSA
Graybug Vision Graybug Vision
GRAY
 		- -11.23 % $ 9.65 M Nasdaq Global Market usaUSA
Galera Therapeutics Galera Therapeutics
GRTX
 		- -32.59 % $ 7.61 M Nasdaq Global Market usaUSA
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
 		- 1.35 % $ 17.8 M Nasdaq Capital Market chinaChina
Novavax Novavax
NVAX
 		$ 9.78 -8.22 % $ 1.58 B Nasdaq Global Select Market usaUSA
Hepion Pharmaceuticals Hepion Pharmaceuticals
HEPA
 		- -18.79 % $ 39.3 K Nasdaq Capital Market usaUSA
Hoth Therapeutics Hoth Therapeutics
HOTH
 		- - $ 18.8 M Nasdaq Global Select Market usaUSA
IMARA IMARA
IMRA
 		- 15.96 % $ 663 M Nasdaq Global Select Market usaUSA
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
 		- - $ 1.45 B Nasdaq Global Select Market britainBritain
KemPharm KemPharm
KMPH
 		- -0.34 % $ 200 M Nasdaq Capital Market usaUSA
Kezar Life Sciences Kezar Life Sciences
KZR
 		- - $ 53.3 M Nasdaq Global Select Market usaUSA
Lixte Biotechnology Holdings Lixte Biotechnology Holdings
LIXT
 		- - $ 63.4 M Nasdaq Capital Market usaUSA
Magenta Therapeutics Magenta Therapeutics
MGTA
 		- -7.74 % $ 41.6 M Nasdaq Global Select Market usaUSA
NovaBay Pharmaceuticals NovaBay Pharmaceuticals
NBY
 		- - $ 11.3 M NYSE American usaUSA
NeuroBo Pharmaceuticals NeuroBo Pharmaceuticals
NRBO
 		- 0.43 % $ 12 M Nasdaq Global Select Market usaUSA
OncoCyte Corporation OncoCyte Corporation
OCX
 		- 17.22 % $ 355 K NYSE American usaUSA
Onconova Therapeutics Onconova Therapeutics
ONTX
 		- -0.47 % $ 21 M Nasdaq Capital Market usaUSA
Opthea Limited Opthea Limited
OPT
 		- - $ 1.2 B Nasdaq Global Select Market australiaAustralia
Verastem Verastem
VSTM
 		$ 9.38 -4.82 % $ 650 M Nasdaq Global Market usaUSA
BiomX BiomX
PHGE
 		$ 1.85 14.2 % $ 3.02 M NYSE American israelIsrael
Pieris Pharmaceuticals Pieris Pharmaceuticals
PIRS
 		- -15.58 % $ 1.22 B Nasdaq Capital Market germanyGermany
Plus Therapeutics Plus Therapeutics
PSTV
 		- - $ 301 M Nasdaq Capital Market usaUSA
Pluristem Therapeutics Pluristem Therapeutics
PSTI
 		- -1.9 % $ 33.3 M Nasdaq Global Select Market israelIsrael

References

  1. Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.